Clinical trial
Chlorproguanil-Dapsone in Pregnant Women
NCT00126971 · Centers for Disease Control and Prevention, U.S. Fed · Terminated
Key facts
| NCT number | NCT00126971 |
|---|---|
| Title | Chlorproguanil-Dapsone in Pregnant Women |
| Official title | Pharmacokinetics of Chlorproguanil-Dapsone in Pregnant Women With Plasmodium Falciparum Infection, and Reinfection With P. Falciparum During Pregnancy Following Treatment |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Malaria Research and Training Center, Bamako, Mali Liverpool School of Tropical Medicine |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | chlorproguanil-dapsone |
| Enrollment | 132 |
| Start date | Jul 1, 2005 |
| First posted | Aug 5, 2005 |
| Last update posted | Apr 20, 2025 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: